Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.86 | N/A |
| PEG Ratio (TTM) | 0.25 | N/A |
| P/S Ratio (TTM) | 1.46 | N/A |
| P/B Ratio (TTM) | 0.96 | N/A |
| P/FCF Ratio (TTM) | 13.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.09 | N/A |
| Price to 5YR AVG FCF Ratio | 0.08 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.99% | N/A |
| ROE (TTM) | 4.04% | N/A |
| Net Profit Margin (TTM) | 6.38% | N/A |
| ROIC 5YR AVG | 3.62% | N/A |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 868.63% | 219.50% | 128.48% |
| Revenue | 3.35% | 21.90% | 16.88% |
| Net Income | 867.47% | 217.21% | 126.97% |
| Cash Flow | 20.17% | 55.31% | 25.25% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | N/A |
| Quick Ratio (TTM) | 0.77 | N/A |
| D/E Ratio (TTM) | 0.73 | N/A |
| Interest Coverage (TTM) | 2.11 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.62 | N/A |
| LTL to 5YR AVG FCF | 9.17 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.71% | N/A |